Recurrent Event Analyses in Patients Receiving Maintenance Dialysis and the Effect of Higher- Versus Lower-Dose Chronic Intravenous Iron Therapy: A Report Focusing on Heart Failure Events from the PIVOTAL Trial
A higher dose of chronic intravenous iron therapy compared to a lower dose substantially reduced the total burden of important recurrent events of death and CV disease in patients with end-stage kidney disease receiving maintenance haemodialysis therapy.
Authors
- Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
- John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
- Khawaja M. Talha (ORCID: https://orcid.org/0000-0003-0351-4464)
- Chante Reid (ORCID: https://orcid.org/0000-0003-2530-6025)
- Patrick Barry Mark (ORCID: https://orcid.org/0000-0003-3387-2123)
- Ken Farrington (ORCID: https://orcid.org/0000-0001-8862-6056)
- Stefan D. Anker
- Claire White (ORCID: https://orcid.org/0000-0002-1476-463X)
- David Collins. Wheeler (ORCID: https://orcid.org/0000-0003-0745-3478)
- Sunil Bhandari (ORCID: https://orcid.org/0000-0002-0996-9622)
- Charles Tomson (ORCID: https://orcid.org/0000-0002-0224-8726)
- Iain C. Macdougall (ORCID: https://orcid.org/0000-0001-9804-0657)
- Michele Robertson (ORCID: https://orcid.org/0000-0002-8425-2592)
- Ian Ford
- Philip A. Kalra
- C. G. Winearls
Institutions
- Loyola University Medical Center (US)
- Hull University Teaching Hospitals NHS Trust (GB)
- Lister Hospital (GB)
- Salford Royal NHS Foundation Trust (GB)
- Churchill Hospital (GB)
- Freeman Hospital (GB)
- British Heart Foundation (GB)
- University of Oxford (GB)
- German Centre for Cardiovascular Research (DE)
- King's College Hospital (GB)
- University College London (GB)
- Hull York Medical School (GB)
- Charité - Universitätsmedizin Berlin (DE)
- University of Glasgow (GB)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1002/ejhf.3670
- Citations
- 1
- Primary Topic
- Iron Metabolism and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Kidney Research UK